Category:

EuroDry (EDRY) – Recovering Rates and Greater Liquidity Enhance Outlook

Posted on by cpatches


Tuesday, October 14, 2025

EuroDry Ltd. was formed on January 8, 2018 under the laws of the Republic of the Marshall Islands to consolidate the drybulk fleet of Euroseas Ltd. into a separate listed public company. EuroDry was spun-off from Euroseas Ltd. on May 30, 2018; it trades on the NASDAQ Capital Market under the ticker EDRY. EuroDry operates in the dry cargo, drybulk shipping market. EuroDry’s operations are managed by Eurobulk Ltd., an ISO 9001:2008 and ISO 14001:2004 certified affiliated ship management company and Eurobulk (Far East) Ltd. Inc., which are responsible for the day- to-day commercial and technical management and operations of the vessels. EuroDry employs its vessels on spot and period charters and under pool agreements.

Mark Reichman, Managing Director, Equity Research Analyst, Natural Resources, Noble Capital Markets, Inc.

Hans Baldau, Associate Analyst, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Vessel sale enhances liquidity. EuroDry recently announced an agreement to sell the M/V Eirini P. to a third party for approximately $8.5 million, with the transaction expected to close in October 2025. The sale is projected to generate a gain of approximately $0.6 million, or roughly $0.21 per share. The proceeds will enhance near-term liquidity and strengthen EuroDry’s flexibility to pursue selective investments in more efficient vessels.

Market environment improving. The dry-bulk market has shown signs of recovery as charter rates have recently rebounded from multi-year lows. The improvement reflects strengthening market sentiment, supported by limited fleet growth and rising expectations for Chinese demand. A historically low orderbook and modest fleet expansion provide a constructive foundation for rate stabilization heading into 2026.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

Alliance Entertainment Holding (AENT) – Noble Virtual Conference Highlights

Posted on by cpatches


Tuesday, October 14, 2025

Michael Kupinski, Director of Research, Equity Research Analyst, Digital, Media & Technology , Noble Capital Markets, Inc.

Jacob Mutchler, Research Associate, Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Management appeared confident. Bruce Ogilvie, Executive Chairman, and Jeffrey Walker, CEO, presented at Noble’s October 8th & 9th Virtual Emerging Growth Conference. This report highlights the company’s presentation and fireside Q&A chat, which provided a sanguine outlook for improved margins into fiscal 2026. Investors may listen to the company’s presentation here. 

Favorable margin expansion outlook. Operating margins are expected to expand in fiscal 2026, supported by a full year of the company’s high margin licensing deal with Paramount and development of its Handmade by Robots collectible line. In addition, management anticipates further operating efficiencies. 


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

BioCryst to Acquire Astria Therapeutics, Expanding HAE Portfolio with Late-Stage Injectable Candidate

Posted on by cpatches

Move expected to strengthen BioCryst’s presence in hereditary angioedema and sustain double-digit growth trajectory

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) has announced plans to acquire Astria Therapeutics, Inc. (NASDAQ: ATXS) in a cash-and-stock transaction valued at approximately $700 million in enterprise value, or about $920 million in aggregate equity value. The deal is designed to expand BioCryst’s hereditary angioedema (HAE) portfolio and enhance its long-term growth prospects.

Under the terms of the agreement, Astria shareholders will receive $8.55 in cash and 0.59 shares of BioCryst common stock for each Astria share. Based on BioCryst’s 20-day volume-weighted average price of $7.54 as of October 8, 2025, the consideration represents an implied value of $13.00 per Astria share, a 53% premium to Astria’s October 13 closing price and a 71% premium to its 20-day VWAP. The transaction, unanimously approved by both boards, is expected to close in the first quarter of 2026, subject to customary conditions. Upon completion, Astria CEO Jill C. Milne, Ph.D., will join the BioCryst board of directors.

The acquisition adds navenibart, Astria’s late-stage, long-acting monoclonal antibody inhibitor of plasma kallikrein, currently in Phase 3 clinical development for HAE prophylaxis. Navenibart’s extended dosing schedule—every three to six months—could offer patients a more convenient alternative to existing injectable treatments.

“With navenibart, BioCryst gains a perfectly complementary second product candidate that fits seamlessly within our HAE core competency,” said Jon Stonehouse, CEO of BioCryst. “Together with Orladeyo, we can offer patients both oral and injectable options that address diverse needs, while driving sustainable growth and profitability.”

The addition of navenibart positions BioCryst to broaden its presence in the rare-disease market. The company expects top-line data from the pivotal ALPHA-ORBIT trial in early 2027 and projects a commercial opportunity among more than 5,000 patients currently treated with injectable prophylaxis for HAE.

BioCryst will also acquire STAR-0310, Astria’s early-stage program for atopic dermatitis, though it plans to pursue strategic alternatives for that asset. Financially, the company anticipates that the transaction will maintain its non-GAAP profitability and positive cash flow, while providing meaningful synergies and accretion to operating profit in the first full year following navenibart’s expected launch. BioCryst projects Orladeyo sales of $580 million to $600 million in 2025, up 34% year-over-year in 2024, and expects the acquisition to reinforce a double-digit growth trajectory through the next decade.

Google to Invest $15 Billion in First AI Hub in India

Posted on by cpatches

New Visakhapatnam facility to accelerate AI innovation, expand infrastructure, and strengthen India–U.S. tech collaboration

Google announced plans to establish its first artificial intelligence (AI) hub in Visakhapatnam (Vizag), Andhra Pradesh, marking its largest-ever investment in India. The $15 billion (USD) commitment, spread over five years from 2026 to 2030, will create a world-class AI and data center ecosystem designed to advance India’s digital and economic transformation.

The new AI hub will integrate AI infrastructure, data center capacity, clean energy generation, and an expanded fiber-optic network, positioning Visakhapatnam as a major AI and connectivity hub for both India and global markets. Developed in partnership with AdaniConneX and Airtel, the purpose-built data center campus will provide gigawatt-scale compute capacity and support low-latency, high-performance AI workloads.

“This digital infrastructure will go a long way in meeting the goals of our India AI mission,” said Shri Ashwini Vaishnaw, India’s Minister for IT. “We thank Google for making this $15 billion investment and for helping re-skill and upskill our IT professionals as part of their agenda.”

Thomas Kurian, CEO of Google Cloud, described the investment as a “landmark step in India’s digital future,” adding that the project reflects a shared commitment by the Indian and U.S. governments to harness AI responsibly for societal benefit.

The initiative aligns with India’s Viksit Bharat 2047 vision, which seeks to drive AI-powered innovation and digital inclusion. According to Google, the hub is expected to generate at least $15 billion in U.S. GDP over five years, reflecting new cross-border economic activity driven by cloud and AI adoption.

The AI hub will also include construction of a new international subsea gateway, connecting multiple subsea cables to Visakhapatnam and integrating with Google’s global network of over two million miles of terrestrial and subsea fiber. The gateway will enhance India’s digital resilience and provide new high-capacity, low-latency pathways that complement existing cable landings in Mumbai and Chennai.

When operational, the Visakhapatnam hub will join Google’s network of AI data centers across 12 countries, benefiting from technology developed by R&D teams in Bengaluru, Hyderabad, and Pune. The project will also advance Google’s sustainability goals, incorporating clean energy generation, transmission lines, and storage systems in Andhra Pradesh to power the facility responsibly.

The announcement comes amid ongoing trade tensions between India and the U.S., including recent tariff disputes and calls for boycotts of foreign goods. Despite the backdrop, Indian officials have reaffirmed their commitment to supporting U.S. investment and facilitating ease of business for multinational partners.

Google’s $15 billion plan follows the company’s broader global data center expansion, with $85 billion in infrastructure spending expected this year alone as demand for AI-driven services accelerates worldwide.

Release – V2X Appoints Jeff Cheatham as Vice President of Contracts and Subcontracts

Posted on by aweinsoff@channelchek.com
V2X (PRNewsfoto/V2X, Inc.)

Research News and Market Data on VVX

October 13, 2025

RESTON, Va., Oct. 13, 2025 /PRNewswire/ — V2X, Inc. (NYSE: VVX), today announced the appointment of Jeff Cheatham as Vice President of Contracts and Subcontracts. In this role, Cheatham will oversee all contract strategy, negotiation, and administration activities across the enterprise, ensuring excellence in execution, compliance, and customer engagement in support of V2X’s global operations. He will report to V2X General Counsel, Jeremy Nance.

Cheatham brings more than 25 years of experience in federal contracting, procurement, and business leadership. He joins V2X from Peraton, where he most recently served as Vice President of Contracts. Throughout his career, he has successfully led large-scale contracts organizations, negotiated multi-billion-dollar agreements, and implemented strategic initiatives that strengthened operational performance and profitability.

“Jeff’s extensive experience and leadership in contracts and procurement make him an exceptional addition to our team,” said Jeremy Nance, General Counsel at V2X. “His proven ability to drive operational excellence and foster collaboration across complex organizations aligns perfectly with our mission to deliver trusted, innovative solutions to our customers worldwide.”

Cheatham holds a Master of Business Administration from the University of Maryland’s Robert H. Smith School of Business and a Bachelor of Science in Economics, cum laude, from George Mason University.

About V2X
V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission’s lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today’s toughest challenges across all operational domains.

Investor Contact
Mike Smith, CFA
Vice President, Treasury, Corporate Development and Investor Relations
IR@goV2X.com
719-637-5773

Media Contact
Angelica Spanos Deoudes
Director, Corporate Communications
Angelica.Deoudes@goV2X.com
571-338-5195

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-appoints-jeff-cheatham-as-vice-president-of-contracts-and-subcontracts-302581605.html

SOURCE V2X, Inc.

Release – V2X to Announce Third Quarter 2025 Financial Results

Posted on by aweinsoff@channelchek.com
V2X (PRNewsfoto/V2X, Inc.)

Research News and Market Data on VVX

October 13, 2025

RESTON, Va., Oct. 13, 2025 /PRNewswire/ — V2X, Inc., (NYSE: VVX), a leading provider of global mission solutions, will report third quarter 2025 financial results on Monday, November 3, 2025, after market close. Senior management will conduct a conference call at 4:30 p.m. ET that same day.

U.S.-based participants may dial in to the conference call at 877-300-8521, while international participants may dial 412-317-6026. A live webcast of the conference call as well as an accompanying slide presentation will be available at https://app.webinar.net/80dR21K5Yr9 and on the Investors section of the V2X website at https://gov2x.com/.

A replay of the conference call will be posted on the V2X website shortly after completion of the call and will be available for one year. A telephonic replay will also be available through November 17, 2025, at 844-512-2921 (domestic) or 412-317-6671 (international) with passcode 10202916.  

About V2X
V2X builds innovative solutions that integrate physical and digital environments by aligning people, actions, and technology. V2X is embedded in all elements of a critical mission’s lifecycle to enhance readiness, optimize resource management, and boost security. The company provides innovation spanning national security, defense, civilian, and international markets. With a global team of approximately 16,000 professionals, V2X enables mission success by injecting AI and machine learning capabilities to meet today’s toughest challenges across all operational domains.

Investor Contact
Mike Smith, CFA
Vice President, Treasury, Corporate Development and Investor Relations
IR@goV2X.com
719-637-5773

Media Contact
Angelica Spanos Deoudes
Director, Corporate Communications
Angelica.Deoudes@goV2X.com
571-338-5195

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-to-announce-third-quarter-2025-financial-results-302581312.html

SOURCE V2X, Inc.

Release – GeoVax Leadership to Participate in Key European Meetings to Advance Partnering Discussions

Posted on by aweinsoff@channelchek.com

Research News and Market Data on GOVX

Executives to Participate at World Vaccine Congress Europe (Amsterdam, Oct 13–16) and BIO-Europe Fall (Vienna, Nov 3–5), and Meet With NGOs, Industry Partners and Academic Collaborators

ATLANTA, GA – October 13, 2025 – GeoVax Labs, Inc. (Nasdaq: GOVX), a clinical-stage biotechnology company developing multi-antigen vaccines and immunotherapies for infectious diseases and cancer, today announced that senior leadership will be in Europe over the coming weeks to advance partnering and collaboration engagement across the Company’s portfolio.

Chairman & Chief Executive Officer David A. Dodd and John Sharkey, PhD, Vice President, Business Development & Executive Lead for Mpox/Smallpox, together with other members of GeoVax’s senior team, will attend and host meetings at:

  • World Vaccine Congress Europe 2025 – October 14–16, 2025 | Amsterdam, Netherlands
  • BIO-Europe 2025 Fall – November 3–5, 2025 | Vienna, Austria

In addition to conference activities, the team will conduct meetings with global NGOs, including WHO, UNICEF, CEPI, Gavi, and the Africa CDC, as well as with established and prospective academic institutional collaborators across Europe.

“We are focused on solidifying durable relationships that can accelerate development in support of expanded access to critical vaccines and immunotherapies,” said David A. Dodd, Chairman & CEO of GeoVax. “We’re engaging with global health leaders and prospective partners to align on near-term opportunities in mpox/smallpox preparedness, addressing the critically unmet needs of immunocompromised patients relative to COVID-19, expanding the development breadth of Gedeptin® as neoadjuvant cancer therapy, and to explore complementary collaborations across our broader platform.”

Partnering Focus Areas

GeoVax will highlight opportunities spanning its pipeline and technology platforms, including (but not limited to):

  • GEO-MVA (Mpox/Smallpox vaccine candidate): U.S.-based MVA program designed to accelerate access to a second-source of the critically needed GEO-MVA vaccine and rapid, scalable MVA manufacturing.
  • GEO-CM04S1 (multi-antigen COVID-19 vaccine): Designed to elicit robust T-cell and antibody responses; partnering priorities focused on addressing the current unmet needs of an estimated over 400 million immunocompromised patients worldwide.
  • Gedeptin® (gene-directed enzyme prodrug therapy): A tumor-targeted immuno-oncology approach with potential combination synergies with checkpoint inhibitors, providing a potential new neoadjuvant therapy against solid tumors.
  • Broader MVA platform applications: Hemorrhagic fever and Zika programs; continuous cell-line manufacturing and potential technology-transfer collaborations.

“We continue to receive compelling interest from governments, NGOs, and potential industry collaborators, seeking diversified, resilient vaccine supply and clinically differentiated immunotherapies,” added Dr. John Sharkey. “Our goal is to convert that interest into structured collaborations that accelerate development, manufacturing readiness, and regional availability.”

Request a Meeting

Organizations interested in meeting with GeoVax during WVC Europe (Amsterdam, Oct 14–16) or BIO-Europe Fall (Vienna, Nov 3–5) – or at separate times/locations in Europe – are encouraged to contact:

Additional information about GeoVax and its programs is available at www.geovax.com.

About GeoVax

GeoVax Labs, Inc. is a clinical-stage biotechnology company developing novel vaccines against infectious diseases and therapies for solid tumor cancers. The Company’s lead clinical program is GEO-CM04S1, a next-generation COVID-19 vaccine currently in three Phase 2 clinical trials, being evaluated as (1) a primary vaccine for immunocompromised patients such as those suffering from hematologic cancers and other patient populations for whom the current authorized COVID-19 vaccines are insufficient, (2) a booster vaccine in patients with chronic lymphocytic leukemia (CLL) and (3) a more robust, durable COVID-19 booster among healthy patients who previously received the mRNA vaccines. In oncology the lead clinical program is evaluating a novel oncolytic solid tumor gene-directed therapy, Gedeptin®, having recently completed a multicenter Phase 1/2 clinical trial for advanced head and neck cancers. GeoVax is also developing a vaccine targeting Mpox and smallpox and, based on recent EMA regulatory guidance, anticipates progressing directly to a Phase 3 clinical evaluation, omitting Phase 1 and Phase 2 trials. GeoVax has a strong IP portfolio in support of its technologies and product candidates, holding worldwide rights for its technologies and products. For more information about the current status of our clinical trials and other updates, visit our website: www.geovax.com.

Forward-Looking Statements

This release contains forward-looking statements regarding GeoVax’s business plans. The words “believe,” “look forward to,” “may,” “estimate,” “continue,” “anticipate,” “intend,” “should,” “plan,” “could,” “target,” “potential,” “is likely,” “will,” “expect” and similar expressions, as they relate to us, are intended to identify forward-looking statements. We have based these forward-looking statements largely on our current expectations and projections about future events and financial trends that we believe may affect our financial condition, results of operations, business strategy and financial needs. Actual results may differ materially from those included in these statements due to a variety of factors, including whether: GeoVax is able to obtain acceptable results from ongoing or future clinical trials of its investigational products, GeoVax’s immuno-oncology products and preventative vaccines can provoke the desired responses, and those products or vaccines can be used effectively, GeoVax’s viral vector technology adequately amplifies immune responses to cancer antigens, GeoVax can develop and manufacture its immuno-oncology products and preventative vaccines with the desired characteristics in a timely manner, GeoVax’s immuno-oncology products and preventative vaccines will be safe for human use, GeoVax’s vaccines will effectively prevent targeted infections in humans, GeoVax’s immuno-oncology products and preventative vaccines will receive regulatory approvals necessary to be licensed and marketed, GeoVax raises required capital to complete development, there is development of competitive products that may be more effective or easier to use than GeoVax’s products, GeoVax will be able to enter into favorable manufacturing and distribution agreements, and other factors, over which GeoVax has no control.

Further information on our risk factors is contained in our periodic reports on Form 10-Q and Form 10-K that we have filed and will file with the SEC. Any forward-looking statement made by us herein speaks only as of the date on which it is made. Factors or events that could cause our actual results to differ may emerge from time to time, and it is not possible for us to predict all of them. We undertake no obligation to publicly update any forward-looking statement, whether as a result of new information, future developments or otherwise, except as may be required by law.

Company Contact:

info@geovax.com

678-384-7220

Media Contact:

Jessica Starman

media@geovax.com 

Release – V2X to Showcase Advanced Mission Solutions and Debuts “Tempest” Mobile Fires Platform at AUSA 2025

Posted on by aweinsoff@channelchek.com

Research News and Market Data on VVX

October 13, 2025

RESTON, Va., Oct. 13, 2025 /PRNewswire/ — V2X, Inc. (NYSE: VVX)  will showcase its mission-focused capabilities at the 2025 Association of the United States Army (AUSA) Annual Meeting, taking place Monday, October 13 through Wednesday, October 15 in Washington, D.C.

At this year’s event, V2X will highlight its integrated solutions that enhance U.S. Army readiness and support national security priorities. The company will debut “Tempest,” a rugged, COTS-based Mobile Fires Platform engineered for rapid, limited-exposure missions on the modern battlefield. Built for power, flexibility, and speed, Tempest redefines readiness in motion.

V2X will also feature demonstrations of its Warfighter Training and Readiness Solutions, the Gateway Mission Router (GMR), and its collaboration with Bell on a solution for the U.S. Army’s Flight School Next program, showcasing how V2X continues to drive readiness, modernization, and mission success.

Over the three-day event, V2X will demonstrate key solutions designed to meet the evolving needs of the U.S. Army and its mission partners at Booth #1405 in Exhibit Hall B.

Featured Solutions:

Tempest
Rugged COTS Vehicle with Dual Launchers and Advanced Counter-UAS
Tempest is a rugged, commercially based combat vehicle engineered for rapid, low-exposure missions. Outfitted with dual weapon launchers and a proven Counter-UAS capability, Tempest detects, engages, and defeats Class 2–3 UAS in adverse weather conditions—then withdraws before the enemy can cue effective counterfire. Stationary, trailer-mounted variants are also available for fixed-site defense.

Army Air-to-Ground Operations – Gateway Mission Router (GMR)
The GMR is a cyber-hardened, open-architecture solution that enhances air-to-ground operations and adapts to evolving mission requirements. Through intelligent routing of datalinks and platform capabilities, the GMR enables a comprehensive common operating picture, blending situational awareness and command-and-control data across multiple formats. New enhancements, including Wireless Intercom Capability and Maintenance Data Offload, expand GMR’s functionality in support of the Department of Defense’s Combined Joint All-Domain Command and Control initiative.

Army Aviation – Flight School Next
At Fort Novosel, the home of Army Aviation, V2X is collaborating with Bell Helicopter to support the U.S. Army’s Flight School Next program, training the next generation of Army aviators. With decades of aircraft maintenance experience supporting high-OPTEMPO DoD aviation training programs, V2X is uniquely qualified to deliver mission-ready aircraft and sustainment support to Bell and the Aviation Center of Excellence.

Warfighter Training Readiness Solutions
V2X provides enterprise-wide support for the U.S. Army’s Training Aids, Devices, Simulators, and Simulations (TADSS) network, offering flexible and scalable solutions that strengthen warfighter readiness. This initiative ensures that U.S. forces have access to the training and simulation tools needed to maintain mission readiness across all operational domains.

Media Contact
Angelica Spanos Deoudes
Director, Corporate Communications
Angelica.Deoudes@goV2X.com 
571-338-5195

Investor Contact
Mike Smith, CFA
Vice President, Treasury, Corporate Development and Investor Relations
IR@goV2X.com
719-637-5773

Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/v2x-to-showcase-advanced-mission-solutions-and-debuts-tempest-mobile-fires-platform-at-ausa-2025-302581619.html

SOURCE V2X, Inc.

Release – Alliance Resource Partners, L.P. Announces Third Quarter 2025 Earnings Conference Call

Posted on by aweinsoff@channelchek.com

Research News and Market Data on ARLP

October 13, 2025

TULSA, Okla.–(BUSINESS WIRE)– Alliance Resource Partners, L.P. (NASDAQ: ARLP) will report its third quarter 2025 financial results before the market opens on Monday, October 27, 2025. Alliance management will discuss these results during a conference call beginning at 10:00 a.m. Eastern that same day.

To participate in the conference call, dial U.S. Toll Free (877) 407-0784 and request to be connected to the Alliance Resource Partners, L.P. earnings conference call. International callers should dial (201) 689-8560 and request to be connected to the same call. Investors may also listen to the call via the “Investors” section of ARLP’s website at www.arlp.com.

An audio replay of the conference call will be available for approximately one week. To access the audio replay, dial U.S. Toll Free (844) 512-2921; International Toll (412) 317-6671 and request to be connected to replay using access code 13756408.

About Alliance Resource Partners, L.P.

ARLP is a diversified energy company that is currently the second largest coal producer in the eastern United States, supplying reliable, affordable energy domestically and internationally to major utilities, metallurgical and industrial users. ARLP also generates operating and royalty income from mineral interests it owns in strategic coal and oil & gas producing regions in the United States. In addition, ARLP is positioning itself as a reliable energy partner for the future by pursuing opportunities that support the growth and development of energy and related infrastructure.

News, unit prices and additional information about ARLP, including filings with the Securities and Exchange Commission (“SEC”), are available at www.arlp.com. For more information, contact the investor relations department of ARLP at (918) 295-7673 or via e-mail at investorrelations@arlp.com.

Investor Relations
Cary P. Marshall
Senior Vice President and Chief Financial Officer
(918) 295-7673
investorrelations@arlp.com

Source: Alliance Resource Partners, L.P.

Resources Connection (RGP) – Post Call Commentary

Posted on by cpatches


Monday, October 13, 2025

Resources Connection, Inc. provides agile consulting services in North America, Europe, and the Asia Pacific. The company offers finance and accounting services, including process transformation and optimization, financial reporting and analysis, technical and operational accounting, merger and acquisition due diligence and integration, audit readiness, preparation and response, implementation of new accounting standards, and remediation support. It also provides information management services, such as program and project management, business and technology integration, data strategy, and business performance management. In addition, the company offers corporate advisory, strategic communications, and restructuring services; and corporate governance, risk, and compliance management services, such as contract and regulatory compliance, enterprise risk management, internal controls management, and operation and information technology (IT) audits. Further, it provides supply chain management services comprising strategy development, procurement and supplier management, logistics and materials management, supply chain planning and forecasting, and unique device identification compliance; and human capital services, including change management, organization development and effectiveness, compensation and incentive plan strategies, and optimization of human resources technology and operations. Additionally, the company offers legal and regulatory supporting services for commercial transactions, global compliance initiatives, law department operations, and law department business strategies and analytics. It also provides policyIQ, a proprietary cloud-based governance, risk, and compliance software application. The company was formerly known as RC Transaction Corp. and changed its name to Resources Connection, Inc. in August 2000. Resources Connection, Inc. was founded in 1996 and is headquartered in Irvine, California.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Some Positives. The Company continues on its transformation path and is seeing encouraging signs, in our opinion. For example, the Company saw a return to growth in revenue for both the Europe & Asia- Pac segment and the Outsourced Services segment, with 5% and 4% growth over the prior year quarter. Revenue from the top 10 clients also grew year-over-year, and the enterprise-wide average bill rate increased to $120 on a constant currency basis, up from $118 a year ago.

Ongoing Cost Focus. The other side of the transformation plan is a focus on cost control. RGP continues to make good progress on its SG&A, as reflected in the quarter’s numbers. Post quarter, on September 30, 2025, in the face of continued end market sluggishness, RGP commenced a global reduction in its management and administrative workforce intended to enhance efficiencies through reduced costs and streamlined operations. Management expects approximately $6 million to $8 million of annual cost savings associated with this effort.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

NN (NNBR) – Noble Virtual Conference Highlights

Posted on by cpatches


Monday, October 13, 2025

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Noble Virtual Conference. NN CEO Harold Bevis, CFO Chris Bohnert, and COO Tim French presented at the Noble Virtual Conference. Highlights included improving end markets outlook, an on track new business win program, and a focus on de-leveraging. A rebroadcast is available at https://www.channelchek.com/videos/nn-inc-nnbr-noble-capital-markets-virtual-conference-replay-october-2025.

Phase 2. NN is entering Phase 2 of its transformation program. Phase 1 structurally rebuilt NN’s operating performance and efficiency through fixing unprofitable areas, improving margins, and entering new markets. Phase 2 is a growth and de-leverage focus, implementing new business programs, expanding the TAM, and addressing the preferred stock.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

FAT Brands (FAT) – Some Legal Resolution

Posted on by cpatches


Monday, October 13, 2025

FAT Brands (NASDAQ: FAT) is a leading global franchising company that strategically acquires, markets, and develops fast casual, quick-service, casual dining, and polished casual dining concepts around the world. The Company currently owns 17 restaurant brands: Round Table Pizza, Fatburger, Marble Slab Creamery, Johnny Rockets, Fazoli’s, Twin Peaks, Great American Cookies, Hot Dog on a Stick, Buffalo’s Cafe & Express, Hurricane Grill & Wings, Pretzelmaker, Elevation Burger, Native Grill & Wings, Yalla Mediterranean and Ponderosa and Bonanza Steakhouses, and franchises and owns over 2,300 units worldwide. For more information on FAT Brands, please visit www.fatbrands.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Legal Resolution. In an 8-K filing, FAT Brands disclosed that the Company and certain current and former directors and officers have reached a settlement agreement with stockholders of the Company to resolve two lawsuits known as Harris I and Harris II. The Derivative Actions were filed in June 2021, relating to the Company’s December 2020 merger with Fog Cutter Capital Group, and in March 2022, relating to the Company’s June 2021 recapitalization.

Details. Under the terms of the settlement agreement, the Company’s Board of Directors agreed to adopt and implement certain corporate governance modifications. In addition, the Company’s insurers will pay to the Company $10 million, from which fees and expenses of plaintiffs’ counsel will be deducted, and Fog Cutter Holdings LLC will contribute 200,000 Class A shares of Twin Hospitality Group Inc. to the Company.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision. 

CoreCivic, Inc. (CXW) – Noble Virtual Conference Highlights

Posted on by cpatches


Monday, October 13, 2025

CoreCivic is a diversified, government-solutions company with the scale and experience needed to solve tough government challenges in flexible, cost-effective ways. We provide a broad range of solutions to government partners that serve the public good through high-quality corrections and detention management, a network of residential and non-residential alternatives to incarceration to help address America’s recidivism crisis, and government real estate solutions. We are the nation’s largest owner of partnership correctional, detention and residential reentry facilities, and believe we are the largest private owner of real estate used by government agencies in the United States. We have been a flexible and dependable partner for government for nearly 40 years. Our employees are driven by a deep sense of service, high standards of professionalism and a responsibility to help government better the public good. Learn more at www.corecivic.com.

Joe Gomes, CFA, Managing Director, Equity Research Analyst, Generalist , Noble Capital Markets, Inc.

Refer to the full report for the price target, fundamental analysis, and rating.

Noble Virtual Conference. CoreCivic CFO David Garfinkle and Managing Director of Investor Relations Jeb Bachmann presented at the Noble Virtual Conference. Highlights included increased demand, long-term trends, and return of capital. A rebroadcast is available at https://www.channelchek.com/videos/corecivic-cxw-noble-capital-markets-virtual-conference-replay-october-2025.

Market Share. CoreCivic remains the largest non-government owner of correctional and detention real estate in the U.S., owning approximately 57% of all privately owned correctional and detention capacity. The Company manages approximately 41% of all privately managed correctional and detention capacity.


Get the Full Report

Equity Research is available at no cost to Registered users of Channelchek. Not a Member? Click ‘Join’ to join the Channelchek Community. There is no cost to register, and we never collect credit card information.

This Company Sponsored Research is provided by Noble Capital Markets, Inc., a FINRA and S.E.C. registered broker-dealer (B/D).

*Analyst certification and important disclosures included in the full report. NOTE: investment decisions should not be based upon the content of this research summary. Proper due diligence is required before making any investment decision.